Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine Once Daily vs Twice Daily in Antiretroviral-Naive HIV-1 Adults
NCT00004852Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 1999
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Started Sep 1999; status: completed.
02
Drugs
lamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00004852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004852.